Agnize Life Science Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 14-06-2024
- Paid Up Capital ₹ 4.95 Cr
as on 14-06-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 8.00 Cr
as on 14-06-2024
- Revenue %
(FY 2022)
- Net Worth 3263.72%
(FY 2022)
- Total Assets 1091.22%
(FY 2022)
About Agnize Life Science
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.95 Cr.
The company currently has active open charges totaling ₹8.00 Cr.
Nehal Kumar, Sushil Prasad, Pratyush Prasad, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239BR2019PTC058938
- Company No.
345358
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 2019
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Agnize Life Science?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nehal Kumar  | Director | 18-Apr-2023 | Current |
| Sushil Prasad | Director | 01-Feb-2019 | Current |
| Pratyush Prasad | Director | 12-Jul-2022 | Current |
| Yashoda Prasad | Director | 01-Feb-2019 | Current |
| Savitri Prasad | Director | 01-Feb-2019 | Current |
Financial Performance of Agnize Life Science.
Agnize Life Science Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 3263.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Agnize Life Science?
In 2022, Agnize Life Science had a promoter holding of 93.09% and a public holding of 6.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Adamant Bio-Life Private LimitedActive 17 years 6 months
Sushil Prasad and Savitri Prasad are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 05 May 2022 | ₹8.00 Cr | Open |
How Many Employees Work at Agnize Life Science?
Unlock and access historical data on people associated with Agnize Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agnize Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agnize Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
